Executive team
Amy DuRoss, Vice President of Policy and Business Affairs
Amy DuRoss served as chief of staff for the California Institute for Regenerative Medicine, established in 2004 by the passage of Proposition 71, which provides $3 billion in funding for stem cell research in California. More
Sean George, Ph.D., Chief Operating Officer
Before joining Navigenics, Dr. George held numerous posts at Affymetrix, Inc., most recently senior vice president of marketing, responsible for the company's marketing, corporate communications, product management and customer relationship management divisions. Dr. George also served as vice president of life science research at Affymetrix, leading the company's $200 million-dollar academic business in North America, Europe, Japan and China. More
Jonathan “Jack” T. Lord, M.D., President and Chief Executive Officer
Dr. Lord comes to Navigenics from Louisville, Kentucky-based Humana, Inc., where as Chief Innovation Officer he led the development of new products and services to fundamentally transform the healthcare system and support personal health needs. Dr. Lord also led Humana’s international efforts as Chief Executive of Humana Europe. Dr. Lord is a board-certified forensic pathologist with more than three decades of experience in medical practice and leadership. He launched his medical career with the U.S. Navy, where he spent 11 years on active duty and served in leadership positions for the Navy’s Surgeon General and Secretary of the Navy. More
Stephen Moore, General Counsel
Mr. Moore was most recently associate general counsel with Affymetrix, Inc., a publicly traded biotechnology company developing advanced technologies for genetic screening. During his more than eight years at Affymetrix, he was responsible for a wide variety of strategic alliances, collaboration agreements and other transactional matters, including the spin-out of Perlegen Sciences, research collaborations with leading academic institutions such as the Broad Institute of MIT and Harvard, diagnostic product supply agreements and Affymetrix's Translational Medicine program in the United States and Canada. More
Becky Scott, Chief Financial Officer
Before joining Navigenics, Ms. Scott was vice president of finance and administration for BabyCenter, LLC, a wholly owned subsidiary of Johnson & Johnson. She was responsible for managing finance and all core administrative functions, including human resources, legal and facilities, as the company expanded from start-up stage to becoming the pre-eminent online parenting resource it is today. During her time at BabyCenter, she also acted as the company's chief privacy officer and was instrumental in the international rollout of nine new country-specific sites. More
Dietrich Stephan, Ph.D., Co-founder and Chief Science Officer
Dietrich Stephan is a human geneticist on the faculty of the Translational Genomics Research Institute and chairman of the National Institutes of Health Neuroscience Microarray Consortium. He has identified genes that predispose to disorders such as autism, exercise-induced heart attacks and sudden infant death syndrome, and contributed to understanding a multitude of common disorders such as Alzheimer's disease. More
Denise Thomas, Chief Marketing Officer
Ms. Thomas has more than 20 years of experience in marketing and business management. She was formerly executive vice president and chief marketing officer for LesConcierges, a global loyalty and lifestyle services firm, and founder of OffRoad Capital, transforming a pioneering idea into a Web-driven marketplace that attracted more than 7,000 member investors with a net worth of $40 billion. More
Vance Vanier, M.D., Chief Medical Officer
Dr. Vance Vanier is a clinical faculty member of Stanford University Medical Center. As a former partner at venture capital firm Mohr Davidow Ventures, he has spent years in the molecular diagnostics industry bringing new genomic technologies into clinical practice. He serves as a member of the Personalized Medicine Coalition's Clinical Science Committee, Stanford Hospital's Pharmacy and Therapeutics Committee, and the American College of Preventive Medicine. More